Literature DB >> 16971092

Substance abuse in first-episode non-affective psychosis.

Tor K Larsen1, Ingrid Melle, Bjørn Auestad, Svein Friis, Ulrik Haahr, Jan Olav Johannessen, Stein Opjordsmoen, Bjørn Rishovd Rund, Erik Simonsen, Per Vaglum, Thomas H McGlashan.   

Abstract

Abuse of alcohol and drugs is an important and clinically challenging aspect of first-episode psychosis. Only a few studies have been carried out on large-sized and reliably characterized samples. These are reviewed, and the results are compared with a sample of 300 first-episode psychosis patients recruited for the TIPS (Early Treatment and Identification of Psychosis) study from Norway and Denmark. Prevalence rates from the literature vary from 6% to 44% for drugs and 3% to 35% for alcohol. In our sample, 23% abused drugs and 15% abused alcohol during the last 6 months. When compared to non-abusers, the drug-abusing group is characterized by the following: male gender, younger age, better premorbid social, poor premorbid academic functioning, and more contact with friends in the last year before onset. Alcohol abusers were the oldest group and they had the least contact with friends. A group of patients abusing both drugs and alcohol had poor premorbid academic functioning from early childhood. Overall, drug and alcohol abuse are highly prevalent in contemporary first-episode psychosis samples. In our study, substance abuse comorbidity did not generate differences on diagnosis, duration of untreated psychosis, psychiatric symptoms, or global functioning at onset/baseline. The premorbid profiles of the substance abusers were clearly different from the non-abusers. Drug abusers, in particular, were more socially active both premorbidly and during the year preceding the start of treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16971092     DOI: 10.1016/j.schres.2006.07.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.

Authors:  Michael T Compton; Beth Broussard; Claire E Ramsay; Tarianna Stewart
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

2.  Substance abuse and smoking among a Canadian cohort of first episode psychosis patients.

Authors:  Wayne K Deruiter; Chiachen Cheng; Margaret Gehrs; John Langley; Carolyn S Dewa
Journal:  Community Ment Health J       Date:  2013-06-18

3.  Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?

Authors:  Jasmina Mallet; Nicolas Ramoz; Yann Le Strat; Philip Gorwood; Caroline Dubertret
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-02-11       Impact factor: 5.270

4.  Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study.

Authors:  Ragnar Nesvåg; Gun Peggy Knudsen; Inger Johanne Bakken; Anne Høye; Eivind Ystrom; Pål Surén; Anne Reneflot; Camilla Stoltenberg; Ted Reichborn-Kjennerud
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-14       Impact factor: 4.328

5.  Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Authors:  Anne-Marit Langås; Ulrik F Malt; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2011-02-12       Impact factor: 3.630

6.  Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Authors:  A M Auther; D McLaughlin; R E Carrión; P Nagachandran; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2012-04-30       Impact factor: 7.723

Review 7.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

8.  A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.

Authors:  Rachel Miller; Geoffrey Ream; Joanne McCormack; Handan Gunduz-Bruce; Serge Sevy; Delbert Robinson
Journal:  Schizophr Res       Date:  2009-05-28       Impact factor: 4.939

9.  The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.

Authors:  Kim Donoghue; Ian Medley; John Brewin; Cristine Glazebrook; Peter Mason; Roch Cantwell; Peter B Jones; Glynn Harrison; Gillian A Doody
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-12-31       Impact factor: 4.328

10.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.